Search

STAAR Surgical Co

Suletud

SektorTervishoid

23.42 -3.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

23.42

Max

23.73

Põhinäitajad

By Trading Economics

Sissetulek

5.2M

5.2M

Müük

36M

94M

Aktsiakasum

0.29

Kasumimarginaal

5.567

Töötajad

921

EBITDA

19M

10M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+34% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

12. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-192M

1.2B

Eelmine avamishind

26.68

Eelmine sulgemishind

23.42

Uudiste sentiment

By Acuity

53%

47%

268 / 340 Pingereas Healthcare

STAAR Surgical Co Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. juuli 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21. juuli 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20. juuli 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Võrdlus sarnastega

Hinnamuutus

STAAR Surgical Co Prognoos

Hinnasiht

By TipRanks

34% tõus

12 kuu keskmine prognoos

Keskmine 31.33 USD  34%

Kõrge 40 USD

Madal 25 USD

Põhineb 8 Wall Streeti analüütiku instrumendi STAAR Surgical Co 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

6

Hoia

0

Müü

Sentiment

By Acuity

268 / 340 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat